EU Agency Calls For Recall Of US-Made Cancer Drugs

Law360, New York (November 22, 2011, 7:17 PM EST) -- A European regulatory agency on Tuesday recommended recalling three cancer drugs manufactured at a Boehringer Ingelheim GmbH subsidiary's facility in the U.S. after an inspection revealed the risk for potential contamination.

The European Medicines Agency said the recommended recall was a precautionary measure after an inspection earlier in November turned up potential problems with the sterile packaging equipment at Ben Venue Laboratories Inc. in Bedford, Ohio.

The European Union drug regulator called for a recall of Busilvex, Velcade and Vidaza manufactured at Ben Venue. All three...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.